EFFECTS OF ERYTHROPOIETIN IN INFANTS WITH ANEMIA OF PREMATURITY

Chen HW

Department of Pediatrics, Nanfang Hospital, Guangzhou, China

 

Objective: To evaluate the effects of erythropoietin in infants with anemia of prematurity,.

Methods: 53 cases of infants with anemia of prematurity were randomly divided into treatment group (31 cases) and placebo group (22 cases). In the treatment group, erythropoietin was administered subcutaneously in a dose of 200 IU/kg twice a week for 8 weeks.

Results: The hemoglobin, red blood cell and hematocrit in the treatment group were significantly increased and higher than the pacebo group (P<0.001) after 8 weeks.The increasing peak is in the fifth week.No significant side effects were observed.

Conclusion: erythropoietin is effective in the treatment of infants with anemia of prematurity.

 
0646